对比增强能谱乳腺摄影的实质强化能否作为乳腺癌新危险因素?与已知影像学危险因素的相关性
研究对比了CESM与CE-MRI的背景实质强化(BPE),并分析其与激素状态、乳腺X线密度(MBD)及MRI纤维腺体组织体积(FGTV)的关系。66例女性中,CESM BPE与MBD、FGTV及MRI BPE显著相关,读者间一致性优于CE-MRI,且不受月经周期影响;作者认为CESM BPE分级可能有助于乳腺癌风险评估。
要点
- CESM BPE与MBD(rho=0.36)、FGTV(rho=0.52)及MRI BPE(rho=0.49)均显著相关(p<0.0001)。
- CESM BPE读者间一致性为k=0.67(实质一致),优于CE-MRI BPE的k=0.19(轻微一致)。
- 绝经后组CE-MRI与CESM的BPE均显著降低(p<0.05),CESM BPE在月经周期中无显著波动。
核心结论
- CESM BPE与MBD、FGTV及CE-MRI BPE相关,读者间一致性优于CE-MRI,且不受月经周期影响;作者认为CESM BPE分级可能有助于乳腺癌风险评估。
研究设计与样本
- 2012年6月至2015年10月,一项癌症分期研究的参与者接受FFDM、CE-MRI和CESM检查;96例符合条件者中66例女性(35-77岁)完成CESM和CE-MRI;两位读者独立按BI-RADS标准评估FGTV、MBD和BPE;采用加权kappa评估读者间一致性,Spearman相关系数分析BPE与MBD、FGTV的相关性,多水平有序回归分析激素状态关联。
关键影像表现/征象
- CESM BPE与MBD呈显著相关(rho=0.36,p<0.0001)。
- CESM BPE与FGTV呈显著相关(rho=0.52,p<0.0001)。
- CESM BPE与MRI BPE呈显著相关(rho=0.49,p<0.0001)。
- 绝经后组CE-MRI和CESM的BPE均显著降低(p<0.05)。
- CESM BPE在月经周期中无显著波动。
诊断标准与关键数值
- CESM BPE读者间一致性为k=0.67(实质一致)。
- CE-MRI BPE读者间一致性为k=0.19(轻微一致)。
- MRI FGTV读者间一致性为k=0.57(中等一致)。
- MBD读者间一致性为k=0.35(一般一致)。
临床应用与阅片要点
- CESM BPE与MBD、FGTV及CE-MRI BPE相关,作者认为CESM BPE分级可能有助于乳腺癌风险评估。
- CESM BPE读者间一致性优于CE-MRI BPE(k=0.67 vs k=0.19)。
- CESM BPE在月经周期中无显著波动,绝经后组BPE显著降低(p<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To compare background parenchymal enhancement (BPE) on contrast-enhanced (CE) spectral mammography (CESM) with CE magnetic resonance imaging (MRI), and evaluate how these relate to hormonal status, mammographic breast density (MBD) and MRI fibroglandular tissue volume (FGTV).
METHODS AND MATERIALS: Between June 2012 to October 2015, participants in a cancer staging study underwent full-field digital mammography (FFDM), CEMRI, and CESM. Two readers independently rated FGTV, MBD, and BPE using the Breast Imaging-Reporting and Data System (BI-RADS) criteria. Inter-reader reliability was estimated using weighted kappa (k) and correlations between BPE, MBD, and FGTV calculated using Spearman's correlation coefficient. Associations with hormonal status were evaluated using multilevel ordinal regression analysis.
RESULTS: Of the 96 eligible participants, 66 women (35-77 years) underwent CESM and CEMRI. Reasons for exclusion were declined or withdrawn consent (n=18), inadequate renal function (n=2), claustrophobia (n=2), previous reaction to contrast medium (n=2), mild reaction to contrast medium following CESM (n=2), lack of vascular access (n=1), neoadjuvant chemotherapy (n=1), CESM equipment failure (n=1), and unclear in one case. Inter-reader agreement was substantial (k=0.67) for CESM BPE, slight (k=0.19) for CEMRI BPE, moderate (k=0.57) for MRI FGTV and fair (k=0.35) for MBD. CESM BPE showed significant correlation with MBD (rho=0.36, p<0.0001), FGTV (rho=0.52, p<0.0001), and MRI BPE (rho=0.49, p<0.0001). BPE was significantly reduced in the post-menopausal group for CEMRI and CESM (p<0.05). CESM BPE did not significantly fluctuate during the menstrual cycle.
CONCLUSION: CESM BPE is correlated with MBD, FGTV, and CEMRI BPE, has better inter-reader reliability than CEMRI, and is not influenced by the menstrual cycle. Grading the degree of BPE on CESM could be a useful addition to breast cancer risk assessment tools.
引用
- Savaridas SL, Taylor DB, Gunawardana D, et al. Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors. Clin Radiol. 2017. PMID: 28870431. doi:10.1016/j.crad.2017.07.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。